Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial

INTRODUCTION: An estimated 4.3 million people aged ≥ 65 years with diabetes live in Japan. We evaluated the efficacy and safety of linagliptin in older Japanese patients with poorly controlled type 2 diabetes (T2DM). METHODS: In this phase 4, randomised, placebo-controlled national study (part of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Eiichi, Unno, Yuriko, Tanaka, Yuko, Sakamoto, Wataru, Miyamoto, Yuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822821/
https://www.ncbi.nlm.nih.gov/pubmed/31482511
http://dx.doi.org/10.1007/s12325-019-01065-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822821/
https://www.ncbi.nlm.nih.gov/pubmed/31482511
http://dx.doi.org/10.1007/s12325-019-01065-7

Ejemplares similares